FDA
approval
· 2008-05-13
FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (Actavis Pharma, Inc.)
Summary
FDA approved a supplemental application for the topical antifungal and anti-inflammatory combination clotrimazole and betamethasone dipropionate from Actavis Ph…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE (CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE)